Prediction of early progression of metastatic renal cell carcinoma treated with first-line tyrosine kinase inhibitor

BACKGROUND: There are various alternative first-line therapeutic options besides tyrosine kinase inhibitors (TKIs) for metastatic renal cell carcinoma (mRCC). To inform therapeutic decision-making for such patients, this study aimed to identify predictive factors for resistance to TKI. MATERIALS AND...

Descripción completa

Detalles Bibliográficos
Autores principales: Teishima, Jun, Murata, Daiki, Inoue, Shogo, Hayashi, Tetsutaro, Mita, Koji, Hasegawa, Yasuhisa, Kato, Masao, Kajiwara, Mitsuru, Shigeta, Masanobu, Maruyama, Satoshi, Moriyama, Hiroyuki, Fujiwara, Seiji, Matsubara, Akio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Editor Recommendations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8772668/
https://www.ncbi.nlm.nih.gov/pubmed/35069080
http://dx.doi.org/10.1097/CU9.0000000000000042

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8772668/
https://www.ncbi.nlm.nih.gov/pubmed/35069080
http://dx.doi.org/10.1097/CU9.0000000000000042

Ejemplares similares